ArticleHuman cell2026

Integrative bulk and single-cell transcriptomics identify a recurrence-prognostic risk model with exploratory associations with treatment-response phenotypes in colorectal cancer.

Shuai Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.